0001209191-20-036246.txt : 20200612 0001209191-20-036246.hdr.sgml : 20200612 20200612161115 ACCESSION NUMBER: 0001209191-20-036246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200610 FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pasquale Maria E CENTRAL INDEX KEY: 0001736295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 20960312 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER NAME: FORMER CONFORMED NAME: Pasquale Maria P DATE OF NAME CHANGE: 20180402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-10 0 0000879169 INCYTE CORP INCY 0001736295 Pasquale Maria E 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP & General Counsel Common Stock 2020-06-10 4 M 0 1423 68.62 A 24957 D Common Stock 2020-06-10 4 S 0 1423 95.00 D 23534 D Common Stock 2020-06-10 4 M 0 2192 65.36 A 25726 D Common Stock 2020-06-10 4 S 0 2192 94.19 D 23534 D Non Qualified Stock Option (right to buy) 68.62 2020-06-10 4 M 0 1423 0.00 D 2028-07-01 Common Stock 1423 11861 D Non Qualified Stock Option (right to buy) 65.36 2020-06-10 4 M 0 2192 0.00 D 2028-04-09 Common Stock 2192 15058 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. This includes an aggregate of 20,648 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. /s/ Michael J. Purvis, Attorney-In-Fact 2020-06-12